{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:43:37Z","timestamp":1788515017107,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014361","name":"Hubei University of Medicine","doi-asserted-by":"publisher","award":["X202213249010"],"award-info":[{"award-number":["X202213249010"]}],"id":[{"id":"10.13039\/501100014361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.pnpbp.2023.110754","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:14:56Z","timestamp":1679069696000},"page":"110754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical outcomes of recommended active pharmacotherapy agents from NICE guideline for post-traumatic stress disorder: Network meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Zhi-Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Ben","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Xian-Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2023.110754_bb0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fnins.2019.00886","article-title":"Delirium induced by quetiapine and the potential role of Norquetiapine","volume":"13","author":"Almeida","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0010","first-page":"190","author":"Battle","year":"2013","journal-title":"Diagnost. Stat. Man. Ment. Disord. (DSM). CoDAS.25"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jts.22421","article-title":"The International Society for Traumatic Stress Studies new Guidelines for the prevention and treatment of posttraumatic stress disorder: methodology and development process","volume":"32","author":"Bisson","year":"2019","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1192\/bjp.2020.40","article-title":"Evidence-based prescribing for post-traumatic stress disorder","volume":"216","author":"Bisson","year":"2020","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jts.21933","article-title":"Dissociation and posttraumatic stress disorder: a latent profile analysis","volume":"27","author":"Blevins","year":"2014","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0030","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder","volume":"283","author":"Brady","year":"2000","journal-title":"Jama."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1176\/appi.ajp.2017.17050481","article-title":"Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial","volume":"175","author":"Brunet","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: a pilot study","volume":"16","author":"Butterfield","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hup.2238","article-title":"Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study","volume":"27","author":"Carey","year":"2012","journal-title":"Hum Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0050","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1017\/S003329171700349X","article-title":"Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis","volume":"48","author":"Cipriani","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/bjp.175.1.17","article-title":"Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study","volume":"175","author":"Connor","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0060","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-022-06203-8","article-title":"Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine","volume":"(Berl).239","author":"Coutens","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0070","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial","volume":"63","author":"Davidson","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study","volume":"26","author":"Davidson","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.jcp.0000125685.82219.1a","article-title":"A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study","volume":"24","author":"Davis","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpsychires.2020.07.046","article-title":"Pharmacological treatments for adults with post-traumatic stress disorder: a network meta-analysis of comparative efficacy and acceptability","volume":"130","author":"de Moraes","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0090","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/jcm5120117","article-title":"Treatment of post-traumatic stress disorder nightmares at a veterans affairs medical center","volume":"5","author":"Detweiler","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.18176\/resp.00014","article-title":"Influence of the use of atypical antipsychotics in metabolic syndrome","volume":"22","author":"Dom\u00e9nech-Matamoros","year":"2020","journal-title":"Rev. Esp. Sanid. Penit."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4088\/JCP.v68n0508","article-title":"Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting","volume":"68","author":"Friedman","year":"2007","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109211","article-title":"Pharmacological strategies for post-traumatic stress disorder (PTSD): from animal to clinical studies","volume":"218","author":"Gasparyan","year":"2022","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0115","doi-asserted-by":"crossref","first-page":"9532","DOI":"10.3390\/ijms21249532","article-title":"Mechanism of action of atypical antipsychotic drugs in mood disorders","volume":"21","author":"Grinchii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1037\/amp0000473","article-title":"Summary of the clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults","volume":"74","author":"Guideline Development Panel for the Treatment of PTSD in Adults","year":"2019","journal-title":"Am. Psychol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy","volume":"23","author":"Hamner","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0130","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ps.2008.59.10.1184","article-title":"Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans","volume":"59","author":"Harpaz-Rotem","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40263-014-0162-6","article-title":"Role of atypical antipsychotics in the treatment of generalized anxiety disorder","volume":"28","author":"Hershenberg","year":"2014","journal-title":"CNS Drugs."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10401230009147096","article-title":"Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans","volume":"12","author":"Hertzberg","year":"2000","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0145","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin. Res.)"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.medcli.2016.02.025","article-title":"The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA","volume":"147","author":"Hutton","year":"2016","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0155","series-title":"StatPearls","article-title":"Veteran and military mental health issues","author":"Inoue","year":"2021"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0160","series-title":"Psychological and Pharmacological Treatments for Adults with Posttraumatic Stress Disorder (PTSD)","article-title":"AHRQ comparative effectiveness reviews","author":"Jonas","year":"2013"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0165","first-page":"4","article-title":"Posttraumatic stress disorder: the burden to the individual and to society","volume":"61 Suppl 5","author":"Kessler","year":"2000","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0170","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1017\/S0033291717000708","article-title":"Posttraumatic stress disorder in the world mental health surveys","volume":"47","author":"Koenen","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0175","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/ijms22041662","article-title":"Paroxetine-overview of the molecular mechanisms of action","volume":"22","author":"Kowalska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0180","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2011.1080","article-title":"Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial","volume":"306","author":"Krystal","year":"2011","journal-title":"Jama."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0185","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0190","doi-asserted-by":"crossref","first-page":"19r13113","DOI":"10.4088\/JCP.19r13113","article-title":"Dissociation in pharmacokinetic attenuation between Central dopamine D2 receptor occupancy and peripheral blood concentration of antipsychotics: a systematic review","volume":"81","author":"Kurose","year":"2020","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13651501.2017.1291838","article-title":"Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study","volume":"21","author":"Li","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0200","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/da.20176","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults","volume":"24","author":"Marshall","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v63n0305","article-title":"Fluoxetine versus placebo in posttraumatic stress disorder","volume":"63","author":"Martenyi","year":"2002","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JCP.0b013e31803308ce","article-title":"Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study","volume":"27","author":"Martenyi","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0220","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0225","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-018-0664-3","article-title":"Clinical pharmacokinetics of atypical antipsychotics: an update","volume":"57","author":"Mauri","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0230","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v69n0611","article-title":"Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection","volume":"69","author":"Mohamed","year":"2008","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/YIC.0000000000000061","article-title":"A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment","volume":"30","author":"Naylor","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0245","series-title":"National Institute for Health and Care Excellence, England, UK, 2018","article-title":"Post-traumatic stress disorder","author":"NICE Guideline NG116","year":"2018"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0250","first-page":"430","article-title":"VA\/DOD clinical practice guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder: clinician summary","volume":"16","author":"No Authors Listed. NA","year":"2018","journal-title":"Focus (Am. Psychiatr. Publ.)"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004850-200609000-00005","article-title":"Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women","volume":"21","author":"Padala","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0260","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1017\/S0033291711000201","article-title":"A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder","volume":"41","author":"Panahi","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conctc.2015.12.003","article-title":"Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder","volume":"2","author":"Ramaswamy","year":"2016","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0270","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108195","article-title":"Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation","volume":"239","author":"Raut","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0280","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4088\/JCP.v65n1204","article-title":"A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women","volume":"65","author":"Reich","year":"2004","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.9740\/mhc.2022.08.267","article-title":"Prazosin dosed 3 times a day to treat flashbacks related to PTSD: a case report","volume":"12","author":"Richardson","year":"2022","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.v69n0402","article-title":"Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0300","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans","volume":"171","author":"Rothbaum","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0320","article-title":"Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study","volume":"343","author":"Song","year":"2011","journal-title":"BMJ (Clin. Res.)"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0325","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0330","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study","volume":"159","author":"Stein","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0335","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Tucker","year":"2001","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.64719\/pb.4179","article-title":"Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo","volume":"37","author":"Tucker","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0345","first-page":"517","article-title":"Fluoxetine in posttraumatic stress disorder","volume":"55","author":"van der Kolk","year":"1994","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.v68n0105","article-title":"A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance","volume":"68","author":"van der Kolk","year":"2007","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0355","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2016.15070967","article-title":"Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial","volume":"173","author":"Villarreal","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110754_bb0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJMra012941","article-title":"Post-traumatic stress disorder","volume":"346","author":"Yehuda","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0365","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/nrdp.2015.57","article-title":"Post-traumatic stress disorder","volume":"1","author":"Yehuda","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.pnpbp.2023.110754_bb0370","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004714-200204000-00013","article-title":"Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder","volume":"22","author":"Zohar","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:42:32Z","timestamp":1777545752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584623000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":74,"alternative-id":["S0278584623000404"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110754","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of recommended active pharmacotherapy agents from NICE guideline for post-traumatic stress disorder: Network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110754"}}